key: cord-0265509-ozae5mmt
authors: Kang, Yoon-A; Paik, Hyojung; Zhang, Si Yi; Chen, Jonathan; Warr, Matthew R.; Fan, Rong; Passegué, Emmanuelle
title: Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production
date: 2021-09-02
journal: bioRxiv
DOI: 10.1101/2021.09.01.458573
sha: 91ab4c8c8d27658924c23872dec5778ddb9ad003
doc_id: 265509
cord_uid: ozae5mmt

Recent lineage tracing analyses revealed multipotent progenitors (MPP) to be major functional contributors to steady-state hematopoiesis (1–6). However, we are still lacking a precise resolution of myeloid differentiation trajectories and cellular heterogeneity in MPPs. Here, we found that myeloid-biased MPP3 (2, 3) are functionally and molecularly heterogeneous, with a distinct subset of myeloid-primed secretory cells with high endoplasmic reticulum (ER) volume and FcγR expression. We show that FcγR+/ERhigh MPP3 are a transitional population for rapid production of granulocyte/macrophage progenitors (GMP), which directly amplify myelopoiesis through inflammation-triggered secretion of cytokines in the local bone marrow (BM) microenvironment. Our results identify a novel regulatory function for a subset of secretory MPP3 that controls myeloid differentiation through lineage-priming and cytokine production, and act as a self-reinforcing amplification compartment in stress and disease conditions. One-Sentence Summary A secretory subset of multipotent hematopoietic progenitors augment myelopoiesis in stress and diseases conditions.

Abstract: Recent lineage tracing analyses revealed multipotent progenitors (MPP) to be major functional contributors to steady-state hematopoiesis (1) (2) (3) (4) (5) (6) . However, we are still lacking a precise resolution of myeloid differentiation trajectories and cellular heterogeneity in MPPs. Here, we found that myeloid-biased MPP3 (2, 3) are functionally and molecularly heterogeneous, with a distinct subset of myeloid-primed secretory cells with high endoplasmic reticulum (ER) volume 5 and FcgR expression. We show that FcgR + /ER high MPP3 are a transitional population for rapid production of granulocyte/macrophage progenitors (GMP), which directly amplify myelopoiesis through inflammation-triggered secretion of cytokines in the local bone marrow (BM) microenvironment. Our results identify a novel regulatory function for a subset of secretory MPP3 that controls myeloid differentiation through lineage-priming and cytokine production, and act as 10 a self-reinforcing amplification compartment in stress and disease conditions. One-Sentence Summary: A secretory subset of multipotent hematopoietic progenitors augment myelopoiesis in stress and diseases conditions. 15 Main Text: Myelopoiesis is a demand-adapted process where hematopoietic stem cells (HSC) and a collection of progenitor cells integrate signals from their environment and tailor the output of the myeloid lineage to meet the specific needs of the organism and respond to physiological challenges (1, 7, 8) . Emergency myelopoiesis is induced to amplify myeloid cell production either acutely in stress conditions or constitutively in various malignant contexts, and resulting in a major re-20 organization of the hematopoietic stem and progenitor cell (HSPC) compartment at the top of the hematopoietic hierarchy (1, 9) . Quiescent HSCs are first activated leading to expansion of myeloid-biased MPP2 and MPP3 and myeloid-reprogramming of lymphoid-biased MPP4, which result in the formation of self-renewing GMP patches and their expansion into GMP clusters driving local burst production of mature myeloid cells in the BM microenvironment (2, 10, 11) .

The remodeling of the MPP compartment is triggered in part by low Notch and high Wnt activity in HSCs, and by pro-inflammatory cytokines like IL-1, TNFa, or IL-6 that stimulate many steps of this regenerative program to amplify myeloid cell production (10) (11) (12) (13) (14) . Interestingly, HSPCs themselves have been shown to secrete cytokines upon inflammatory stimuli (15) , raising the 5 intriguing possibility that autocrine or paracrine signaling in the local BM niche might control their function. Single cell RNA-sequencing (scRNAseq) analyses and barcoding lineage tracing strategies have also considerably advanced our knowledge of lineage specification and revealed molecular and functional heterogeneity as well as mixed lineage expression patterns in distinct HSPC populations (16) (17) (18) (19) . However, we still lack a clear understanding of the regulatory 10 mechanisms enforcing myeloid lineage commitment at the top of the hematopoietic hierarchy, and the precise role of lineage-biased MPPs in amplifying myeloid cell production. With the current SARS-CoV-2 pandemic and the success of immunotherapy for cancer treatment, there is a welljustified interest in understanding the mechanisms controlling immune cell production particularly as it relates to innate immunity and myeloid cell production. Indeed, studies of "trained immunity" 15 and the discovery of "central trained immunity" have demonstrated the importance of myeloid progenitors in the regulation of innate immune responses (20) . Here, we show that a subset of secretory MPP3 acts as a self-reinforcing amplification compartment controlling myeloid differentiation in stress and disease conditions through both lineage-priming and differential cytokine production in the local BM niche microenvironment. 20 

To further characterize HSPC secretory activity, we focused on several well-defined phenotypic populations including HSCs (Lin -/c-Kit + /Sca-1 + /Flk2 -/CD48 -/CD150 + ), myeloid-biased MPP3 (Lin -/c-Kit + /Sca-1 + /Flk2 -/CD48 + /CD150 -) and lymphoid-biased MPP4 (Lin -/c-Kit + /Sca-1 + /Flk2 + ), which we compared to myeloid-committed GMPs (Lin -/c-Kit + /Sca-1 -/FcgR + /CD34 + ) (fig. S1A). We found that ~ 1/3 of MPP3 had high endoplasmic reticulum (ER) volume by transmission electron microscopy (TEM) and confirmed the presence of an ER high subset of MPP3 by immunofluorescence microscopy for the ER marker KDEL and flow cytometry 5 staining for the ER-Tracker dye (Fig. 1, A and B, and fig. S1 , B and C). Interestingly, the rough ER structure observed in MPP3 was morphologically similar to the secretory apparatus found in specialized immunoglobulin-producing plasma cells, although MPP3 shared no surface markers with plasma cells (fig. S1, C and D). We directly tested the secretory activity of MPP3 by treating isolated HSPC populations with a previously described inflammatory LPS/Pam3CSK4 (L/P) 10 stimulus (15) , and collecting supernatants after 24 hours for secretome analyses. Stimulated MPP3 secreted higher levels of TNFa and IL-6 than HSCs and MPP4 as shown by ELISA, and displayed a global increase in cytokine secretion akin to GMP as measured with the Raybiotech 200 mouse cytokine array (Fig. 1, C and D) . Detailed examination of each HSPC population revealed specific and complex secretory patterns, with stimulated MPP3 showing increased secretion of many pro- 15 inflammatory and pro-myeloid differentiation cytokines including IL-1a, G-CSF and GM-CSF, and decreased production of regulatory factors controlling immune cell function like TACI or CD40L (Fig. 1E, fig. S1E , and table S1). Consistently, MPP3 also expressed unfolded protein response (UPR) genes in the range of GMPs but to a lower extent than plasma cells (fig. S1F). We next investigated MPP3 secretion at the single cell level using 14 pre-selected cytokines and an S2, C to E). This negative self-regulatory effect of IL-10 was likely overcome in bulk culture due to the strong pro-secretion effect of other cytokines including TNFa itself, which directly modulated IL-6 secretion ( fig. S2F) . We also confirmed a role for the classical mechanisms regulating cellular secretion (23, 24), with inhibition of NF-kB and Ca 2+ -dependent signaling impairing IL-6 secretion from stimulated MPP3 ( fig. S2F ). To directly separate high from low 5 secretory MPP3, we took advantage of their difference in ER volume and sub-fractionated MPP3 into ER high (top 30%) and ER low (bottom 30%) subsets based on ER-Tracker staining (Fig. 1F ).

We confirmed significantly higher secretion of many cytokines, including TNFa and IL-6, in stimulated ER high MPP3 ( Fig. 1G and fig. S2G ). To provide further in vivo support to the paracrine effect of MPP3 secretion, we developed a novel immunofluorescence imaging panel to visualize 1H and fig. S3C ). Taken together, these results demonstrate that MPP3 are the most secretory HSPCs, identify a unique subset of ER high MPP3 that robustly produce many proinflammatory/myeloid differentiation cytokines upon inflammatory stimulus, and localize MPP3 15 in the vicinity of other HSPCs in the BM niche in support of a local paracrine and autocrine effect of MPP3 secretion in regulating myelopoiesis.

To gain a better understanding of MPP3 heterogeneity and response to inflammatory stimulation, we performed droplet-based single cell RNA-sequencing (scRNAseq) analyses on 20 MPP3 stimulated with or without LPS/Pam3CSK4 for 6 hours. Data from unstimulated and stimulated MPP3 were harmonized by nearest neighbor integration (25) and uniform manifold approximation and projection (UMAP) representation identified 13 different clusters ( Fig. 2A) .

Previously defined marker genes (8, 19) allowed the identification of 5 immature (c0, c1, c2, c5, c9), 2 inflammatory (c7, c8), 2 intermediate (c3, c11) and 4 myeloid-primed (c4, c6, c10, c12) clusters ( fig. S4A ). Among the last, c4 and c6 were neutrophil-primed, c10 neutrophil/monocyteprimed, and c12 mast cell/basophil-primed clusters, while neither lymphoid, megakaryocyte, or erythroid lineage identity was detected in any clusters consistent with the myeloid-biased 5 properties of MPP3. Slingshot (26) trajectory analyses identified 3 differentiation branches all starting from quiescent HSC (qHSC)-like c0, with branch 1 representing activation towards a cycling MPP state, branch 2 commitment towards myeloid differentiation via metabolically activated intermediates, and branch 3 the emergence of inflammatory subsets following stimulation (Fig. 2B ). Gene ontology (GO) (27) analyses demonstrated enrichment in immune 10 response genes in iHSC-like c8, metabolic process genes in metabolic intermediate c3, and myeloid differentiation genes in myeloid-primed c6, with cell cycle distribution further confirming the progressive activation status of these various MPP3 subsets (Fig. 2C, fig. S4 , B to D, and table S2). Short-term 6 hours inflammatory stimulation particularly amplified the inflammatory branch 3 (c9, c8, c7) commitment, with up-regulation of inflammatory response genes already observed 15 in stimulated qHSC-like c0 (Fig. 2 , D and E). Altogether, these results deconstruct the molecular heterogeneity of the MPP3 compartment with constitutive cell cycle activation and myeloid differentiation trajectories, and inducible production of inflammatory subsets in response to stimulation. 20 We next investigated the function and regulation of this secretory ER high MPP3 subset.

Strikingly, ER high MPP3 were almost exclusively FcgR + but still differed from GMPs in their expression of other HSPC markers ( Fig. 3A and fig. S5A ). Conversely, the FcgR + fraction of MPP3, which corresponds to the myeloid-primed clusters in scRNAseq analyses, was almost entirely ER high (Fig. 3A and fig. S5B ). In fact, a further harmonized scRNAseq UMAP directly projected ER high MPP3 into Fcgr3-expressing myeloid-primed clusters and ER low MPP3 into immature-like clusters ( Fig. 3B and fig. S5C ). Bulk RNA-sequencing and principal component (PC) analyses confirmed the similarity of ER low MPP3 with HSCs and ER high MPP3 with GMPs, with 5 unfractionated MPP3 having a mixed gene identity (Fig. 3C) Compared to ER low MPP3, ER high MPP3 had significantly lower colony-forming capacity in both methylcellulose and single cell differentiation assays in liquid culture, which was also more restricted to myeloid differentiation, as well as faster division kinetics akin to GMPs ( Fig. 3D and   fig. S6, A and B ). UMAP harmonization of our scRNAseq data with previously published myeloid 15 progenitor profiling (7) directly projected ER high MPP3 together with GMPs, while ER low MPP3 appeared more related but still distinct from the transitional CMP population and lineagecommitted MEP population ( fig. S6C ). Short-term in vivo lineage tracing in sub-lethally irradiated recipients directly confirmed that the entire reconstitution potential of MPP3 was provided by ER low MPP3, with ER high MPP3 barely registering for peripheral blood production (Fig. 3E ). In 20 fact, ER low MPP3 (identified as the FcgR -MPP3) were capable of producing ER high MPP3 (identified as FcgR + MPP3) both in vitro in short-term differentiation assays in liquid culture and in vivo following short-term infusion in recipient mice (fig. S6, D and E). FcgR -/ER low MPP3 also significantly contributed to GMP production in vivo, likely through production of quickly differentiating FcgR + /ER high MPP3 as well as by directly giving rise to CMPs ( fig. S7A ). To test the role of MPP3 subsets in myeloid regeneration in vivo, we then used an established anti-Ly6G depletion model that we previously showed induced transient MPP3 expansion prior to GMP and myeloid cell expansion (12) . Remarkably, we found that the expansion of regenerative MPP3 resulted exclusively from an increase in FcgR + /ER high MPP3, highlighting the role of this secretory 5 subset as an amplification compartment in myelopoiesis ( fig. S7B ). Taken together, these results demonstrate that myeloid-primed FcgR + /ER high MPP3 are a short-lived transitional population toward GMP commitment, while immature FcgR -/ER low MPP3 represent the true multipotent part of the MPP3 compartment also capable of generating CMP and other lineage fates.

To understand the role of FcgR + /ER high MPP3 secreted cytokines, we used supernatants 

Finally, we investigated the role of this newly identified FcgR + /ER high MPP3 subset in malignant myelopoiesis. We used our inducible Scl-tTA:TRE-BCR/ABL (BA tTA ) mouse model of myeloproliferative neoplasm (MPN), which we previously characterized for HSPC remodeling and MPP3 expansion associated with leukemic myeloid cell production (10) (11) (12) . Strikingly, we found that the leukemic MPP3 expansion in BA tTA mice was entirely driven by an increase in 5 FcgR + /ER high MPP3 (Fig. 4, A well-known functions in myelopoiesis (33). In fact, un-stimulated BA tTA MPP3 supernatant increased the proliferation of naïve HSC, MPP3 and MPP4 and enhanced myeloid differentiation from naïve HSCs in liquid culture, although to a lower extent and with longer kinetics than LPS/Pam3CSK4 stimulated supernatants ( Fig. 4E and fig. S9E ). Except for LCN2, the cytokines constitutively secreted by BA tTA MPP3 were also found at elevated levels in the BM fluid of BA tTA 5 mice ( fig. S9 , F and G and table S5), suggesting that they could play active roles in disease pathogenesis. Among those, Gal3 has been found highly expressed in various cancers and is a negative prognostic factor for AML patients (34-36). To test the importance of Gal3 secretion for myeloid amplification by leukemic MPP3, we used previously published Gal3 -/mice (37) to cross with BA tTA mice. Gal3 -/mice already showed reduced commitment towards myelopoiesis at steady (12) . Consistently, we found a striking reduction in nuclear b-catenin levels in BA tTA :Gal3 -/-HSCs likely due to increased GSK3b activity caused by the loss of Gal3-20 mediated regulation (Fig. 4H ). In fact, treatment of BA tTA :Gal3 -/-HSCs with a GSK3b inhibitor restored aberrantly high nuclear b-catenin levels in leukemic HSCs (fig. S10C). Altogether, these results demonstrate that constitutive cytokine secretion by leukemic MPP3 plays a key role in enhancing myeloid lineage trajectory and amplifying myeloid cell production, thereby contributing to disease progression. They also identify a pivotal role for Gal3 secreted by BA tTA MPP3 in increasing Wnt activity in leukemic HSPCs, which could be therapeutically targeted to dampen engagement of emergency myelopoiesis pathways in leukemic conditions.

Our results uncovered a previously unappreciated self-regulatory mechanism in the HSPC compartment mediated by a secretory subset of myeloid-biased multipotent progenitors (MPP3) that controls myeloid commitment through lineage priming and amplifies "on demand" myeloid cell production via autocrine and paracrine effects in the local BM niche microenvironment (fig. S10D). In response to an acute inflammatory challenge, the MPP3 compartment is transiently 10 remodeled via the production of inflammatory intermediates to increase the numbers and trigger the secretion of pro-myeloid differentiation cytokines from FcgR + /ER high MPP3. During MPN development, the MPP3 compartment is re-structured with amplification of metabolicallyactivated intermediates that fuel the overproduction of FcgR + /ER high MPP3, which in turn constitutively secrete cytokines reinforcing both myeloid commitment and differentiation. It now and paracrine effects of MPP3-secreted cytokines in tailoring HSCs and other progenitor fate, it is also likely that MPP3 function will underlie some, if not most, of the cell-autonomous HSC behaviors in single cell transplantation experiments. Collectively, our findings identify a novel mechanism regulating myelopoiesis at the early stage of hematopoietic commitment, which represents an ideal cellular compartment to target therapeutically to rebalance lineage output in 5 stress and disease conditions. 

Figs. S1 to S10 15 Tables S1 to S5 Data are means ± S.D., and significance was assessed by a two-tailed unpaired Student's t-test. week-old mice were used as donor for cell isolation, and 8-to 12-week-old congenic mice were used as recipients for transplantation experiments. For BCR/ABL induction, mice were withdrawn from doxycycline (Dox) containing water at 5 week of age. No specific randomization or blinding protocol was used, and both male and female animals were used indifferently in the study.

Staining of hematopoietic cells were performed as described previously 12 Table 3 . Table 5 . Data are means ± S.D. except when indicated, and significance was assessed by a twotailed unpaired Student's t-test except when indicated. Model depicting the novel regulatory function of a subset of secretory FcgR + /ER high MPP3 that controls myeloid differentiation through lineage-priming and cytokine production. Although FcgR + /ER high MPP3 act as a self-reinforcing compartment amplifying myeloid cell production in both stress and disease conditions, the actual mechanisms of lineage priming and secretion types are context dependent and specific to inflammatory signals or leukemia-driven genetics events. Data are means ± S.D., and significance was assessed by a two-tailed unpaired Student's t-test. 

Normal Hematopoiesis Is a Balancing Act of Self-Renewal and Regeneration

Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions

Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis

Clonal dynamics of native haematopoiesis

Fundamental properties of unperturbed haematopoiesis from stem cells in vivo

Clonal analysis of lineage fate in native haematopoiesis

Transcriptional Heterogeneity and Lineage Commitment in Myeloid 15 Progenitors

Single-cell analysis of mixed-lineage states leading to a binary cell fate choice

Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis

IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development

Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis

Deregulated Notch and Wnt signaling activates earlystage myeloid regeneration pathways in leukemia

Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal

TNF-alpha Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration

Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis

A single-cell hematopoietic landscape resolves 8 lineage trajectories and 15 defects in Kit mutant mice

Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis

Defining trained immunity and its role in health and disease

Single-Cell Protein Secretion Detection and Profiling